One report stated that miR-181a can repress KRAS, NRAS, and MAPK1 and attenuate AML growth directly through binding to the 3′-untranslated regions of KRAS, NRAS, and MAPK1 [161]. The gene discussed is NRAS; the disease is acute myeloid leukemia.